Posted on 7/14/19
Flex Pharma Announces Approval of all Merger-Related Proposals at Special Meeting
BOSTON--(BUSINESS WIRE)--Flex Pharma, Inc. (Nasdaq: FLKS) today announced that its stockholders approved all proposals relating to its planned merger with Salarius Pharmaceuticals, LLC at Flex Pharma’s . . .
Posted on 7/12/19
Why Cigna Stock Is Sailing Higher Today
What happenedShares of Cigna (NYSE:CI) were sailing 12.4% higher as of 11:05 a.m. EDT on Thursday. The nice jump came after the Trump administration dropped its . . .
Posted on 7/12/19
Here's Why Repligen Gained 62.9% in the First Half of 2019
What happenedShares of Repligen (NASDAQ:RGEN) gained nearly 63% in the first six months of 2019, according to data provided by S&P Global Market Intelligence. The surging . . .
Posted on 7/11/19
H.I.G. Supports MedPro
NEW YORK--(BUSINESS WIRE)--Edgemont Partners, a leading middle market healthcare investment bank which counts clinician services as one of its core areas of expertise, is pleased to . . .
Posted on 7/11/19
Leap Therapeutics Announces Common Stock Purchase Agreements For Up to $21 Million with Lincoln Park Capital
Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced it has entered into common stock purchase agreements for up to . . .
Posted on 7/11/19
Eloxx Pharmaceuticals: Buy, Sell Or Hold?
SummaryToday, we take an in-depth look at small-cap concern Eloxx Pharmaceuticals.The firm's pipeline seems to be making some progress against cystic fibrosis and has multiple 'shots . . .
Posted on 7/10/19
Albireo Provides Mid-Year Clinical Development Update
BOSTON, July 09, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, provided an . . .
Posted on 7/10/19
Day Zero Diagnostics Awarded NIH Funding for Technology
BOSTON--(BUSINESS WIRE)--Day Zero Diagnostics, Inc., an infectious disease diagnostics company using genome sequencing and machine learning to combat the rise of antibiotic-resistant infections, today announced it . . .
Posted on 7/10/19
Thermo Fisher: Steady Performance Comes At A Price
SummaryThermo Fisher continues to see a steady operating performance.A fair valuation has over time built up into a premium valuation at nearly 25 times earnings.While I . . .
Posted on 7/10/19
Why Akebia Therapeutics Is A Worthwhile Contrarian Bet
SummaryAkebia's revenue growth in the last quarter disappointed investors.Stock is about to break below a 52-week low.Contrarian opportunity if revenue growth accelerates in the second half . . .
Posted on 7/9/19
CarePort and GHA Subsidiary Partner to Offer Comprehensive Solutions to Improve Transitions of Care
CarePort partners with Georgia Hospital Health Services to offer care coordination solutions to help smooth care transitions and improve patient outcomes across the stateBOSTON--(BUSINESS WIRE)--CarePort Health, . . .
Posted on 7/9/19
Adlon Therapeutics L.P. Joins the Prescription Drug Safety Network
STAMFORD, Conn.--(BUSINESS WIRE)--Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., today announced it will join the Prescription Drug Safety Network and will advance its commitment to . . .
Posted on 7/9/19
GNS Healthcare Raises $23 Million Led by Cigna Ventures
GNS Healthcare (GNS), a leading precision medicine company, today announced a $23 million Series D fundraising round, led by Cigna Ventures,
Posted on 7/9/19
Fresenius Medical Care North America Invests in BioIntelliSense
Fresenius Medical Care North America (FMCNA), the leading provider of kidney care products and services, announces a major strategic investment in BioIntelliSense, a Denver-based company that . . .
Posted on 7/9/19
Celsius Therapeutics Signs Collaboration Agreement with Janssen
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Celsius Therapeutics, a company focused on the discovery and development of precision therapeutics for patients with autoimmune diseases and cancer, today announced a collaboration . . .
Posted on 7/9/19
Nimbus Therapeutics and Celgene Expand Alliance to Immunotherapy in Oncology
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nimbus Therapeutics, a biotechnology company applying deep computational expertise throughout drug discovery and development, today announced the expansion of its long-term strategic alliance with . . .
Posted on 7/9/19
Why Biogen Stock Has Plummeted in 2019
What happenedBiogen (NASDAQ:BIIB), a blue chip biotech stock, has shed an unsightly 22.3% of its value over the course of the first six months of 2019, . . .
Posted on 7/9/19
Why Bristol-Myers Squibb Stock Plunged in the First Half of 2019
What happenedPrescription drug giant Bristol-Myers Squibb (NYSE:BMY) lost an eye-catching 12.8% of its value during the first six months of 2019, according to data from S&P . . .
Posted on 7/8/19
Environ Skin Care Receives 2019 "Top Medical Skin Care" Aesthetic Everything® Aesthetic and Cosmetic Medicine Award
Environ® Skin Care was voted a "Top Medical Skin Care" company in the Aesthetic Everything® Awards. This year's 2019 Aesthetic Everything® Awards tapped winners from over . . .
Posted on 7/8/19
Gamida Cell Announces Option to Purchase Additional Shares
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that the underwriters of its recently closed underwritten public offering of . . .
Posted on 7/9/19
Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics
Gilead will have exclusive rights to Lyndra’s platform for HIV therapiesLyndra Therapeutics, the company making daily pills a thing of the past, has announced a partnership . . .
Posted on 7/8/19
Skyhawk Therapeutics Announces Expansion of Collaboration Agreement with Biogen
Skyhawk Therapeutics, Inc. today announced the expansion of its collaboration with Biogen, originally announced January 4, 2019. The expansion, which capitalizes on the breadth of Skyhawk's . . .
Posted on 7/8/19
Dissecting Thermo Fisher Scientific's Success Over The Past Decade
SummaryThermo Fisher Scientific is a high-growth industrial that brings cutting-edge solutions to the industrial, pharma, and analytical fields.The company's aggressive M&A has paid off, and the . . .
Posted on 7/8/19
Is bluebird bio a Buy?
Gene therapy stocks attracted frenzied attention from investors in 2017 and early 2018, and with good reason. New technologies to manipulate the very software of life . . .
Posted on 7/8/19
Acer Therapeutics Announces Restructuring and Update on Pipeline Programs
NEWTON, Mass., July 05, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for . . .

